Form 4 for AVIR Atea Pharmaceuticals, Inc.
Accepted 2026-02-03 00:00:00 ET · period of report 2026-01-31 · accession 0001193125-26-036281 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-01-31 | AVIR | Horga Maria Arantxa | Chief Medical Off | F - Tax | $4.24 | -16.1K | 96.1K | -14% | -$68.1K |
| D | 2026-02-03 | 2026-01-31 | AVIR | Horga Maria Arantxa | Chief Medical Off | M - OptEx | — | +51.3K | 112.2K | +84% | — |
| DM | 2026-02-03 | 2026-01-31 | AVIR | Horga Maria Arantxa | Chief Medical Off | M - OptEx | $0.00 | -51.3K | 0 | -100% | $0 |
| D | 2026-02-03 | 2026-01-31 | AVIR | Horga Maria Arantxa | Chief Medical Off | A - Grant | $0.00 | +173.5K | 173.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-31 | F | D | 16,073 | $4.24 | 96,086 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-31 | M | A | 51,283 | — | 112,159 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 3 | Derivative | Restricted Stock Units | 2026-01-31 | M | D | 41,533 | $0.00 | 0 | D | — · — to — | 41,533 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F2) The original grant of 124,600 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026. |
| 4 | Derivative | Restricted Stock Units | 2026-01-31 | M | D | 9,750 | $0.00 | 0 | D | — · — to — | 9,750 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F3) Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-01-31 | A | A | 173,500 | $0.00 | 173,500 | D | $4.24 · — to 2036-01-30 | 173,500 Common Stock | (F4) The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030. |